| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | President and Vant Chair | Common Shares | 13.7M | $151M | $10.99 | Jul 30, 2025 | Direct |
| Immunovant, Inc. | Director | Common Stock | 835K | $16.7M | $19.96 | Apr 1, 2025 | Direct |
| Arbutus Biopharma Corp | Director | Stock Option (Right to Buy) | 67K | $188K | $2.81 | May 23, 2024 | Direct |
| Immunovant, Inc. | Director | Stock Option (right to buy) | 93.6K | Apr 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | Jul 30, 2025 | 2 | $0 | 4 | Aug 1, 2025 | President and Vant Chair |
| ROIV | Roivant Sciences Ltd. | Jul 29, 2025 | 0 | $0 | 3 | Jul 29, 2025 | President and Vant Chair |
| IMVT | Immunovant, Inc. | Apr 1, 2025 | 2 | $0 | 4 | Apr 3, 2025 | Director |
| ABUS | Arbutus Biopharma Corp | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| IMVT | Immunovant, Inc. | Apr 2, 2024 | 2 | $0 | 4 | Apr 4, 2024 | Director |
| ABUS | Arbutus Biopharma Corp | May 24, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| IMVT | Immunovant, Inc. | Apr 12, 2023 | 2 | $0 | 4 | Apr 14, 2023 | Director |
| IMVT | Immunovant, Inc. | Sep 29, 2022 | 1 | $116K | 4 | Sep 29, 2022 | Director |
| IMVT | Immunovant, Inc. | Aug 17, 2022 | 2 | $0 | 4 | Aug 19, 2022 | Director |
| ABUS | Arbutus Biopharma Corp | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| IMVT | Immunovant, Inc. | Jan 10, 2022 | 2 | $0 | 4 | Jan 12, 2022 | Director |
| ABUS | Arbutus Biopharma Corp | Jun 3, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |